vs
Side-by-side financial comparison of BayCom Corp (BCML) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $13.8M, roughly 1.9× FENNEC PHARMACEUTICALS INC.). BayCom Corp runs the higher net margin — 26.5% vs -34.7%, a 61.2% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 9.4%). Over the past eight quarters, BayCom Corp's revenue compounded faster (2.9% CAGR vs -26.3%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
BCML vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.9M | $13.8M |
| Net Profit | $6.9M | $-4.8M |
| Gross Margin | — | — |
| Operating Margin | 36.6% | -18.5% |
| Net Margin | 26.5% | -34.7% |
| Revenue YoY | 9.4% | 73.8% |
| Net Profit YoY | 12.1% | -141.1% |
| EPS (diluted) | $0.63 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | $13.8M | ||
| Q3 25 | $25.7M | $12.5M | ||
| Q2 25 | $24.7M | $9.7M | ||
| Q1 25 | $24.3M | $8.8M | ||
| Q4 24 | $23.7M | $7.9M | ||
| Q3 24 | $25.6M | $7.0M | ||
| Q2 24 | $23.8M | $7.3M | ||
| Q1 24 | $24.5M | $25.4M |
| Q4 25 | $6.9M | $-4.8M | ||
| Q3 25 | $5.0M | $-638.0K | ||
| Q2 25 | $6.4M | $-3.2M | ||
| Q1 25 | $5.7M | $-1.2M | ||
| Q4 24 | $6.1M | $-2.0M | ||
| Q3 24 | $6.0M | $-5.7M | ||
| Q2 24 | $5.6M | $-5.6M | ||
| Q1 24 | $5.9M | $12.8M |
| Q4 25 | 36.6% | -18.5% | ||
| Q3 25 | 26.3% | -1.5% | ||
| Q2 25 | 35.3% | -28.3% | ||
| Q1 25 | 31.6% | -9.2% | ||
| Q4 24 | 34.2% | -11.8% | ||
| Q3 24 | 32.4% | -74.6% | ||
| Q2 24 | 31.9% | -69.4% | ||
| Q1 24 | 33.3% | 54.2% |
| Q4 25 | 26.5% | -34.7% | ||
| Q3 25 | 19.5% | -5.1% | ||
| Q2 25 | 25.8% | -32.7% | ||
| Q1 25 | 23.4% | -13.3% | ||
| Q4 24 | 25.9% | -25.0% | ||
| Q3 24 | 23.5% | -82.2% | ||
| Q2 24 | 23.6% | -76.5% | ||
| Q1 24 | 24.0% | 50.6% |
| Q4 25 | $0.63 | $-0.17 | ||
| Q3 25 | $0.46 | $-0.02 | ||
| Q2 25 | $0.58 | $-0.11 | ||
| Q1 25 | $0.51 | $-0.04 | ||
| Q4 24 | $0.55 | $-0.02 | ||
| Q3 24 | $0.54 | $-0.21 | ||
| Q2 24 | $0.50 | $-0.20 | ||
| Q1 24 | $0.51 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.6M | $35.5M |
| Total Assets | $2.6B | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.8M | ||
| Q3 25 | — | $21.9M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $22.7M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $43.1M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $338.6M | $35.5M | ||
| Q3 25 | $334.3M | $-4.5M | ||
| Q2 25 | $330.6M | $-7.5M | ||
| Q1 25 | $329.3M | $-5.9M | ||
| Q4 24 | $324.4M | $-5.9M | ||
| Q3 24 | $321.7M | $-5.2M | ||
| Q2 24 | $315.3M | $-1.4M | ||
| Q1 24 | $314.2M | $3.0M |
| Q4 25 | $2.6B | $70.6M | ||
| Q3 25 | $2.6B | $49.3M | ||
| Q2 25 | $2.6B | $44.9M | ||
| Q1 25 | $2.6B | $46.4M | ||
| Q4 24 | $2.7B | $44.9M | ||
| Q3 24 | $2.6B | $58.9M | ||
| Q2 24 | $2.6B | $63.2M | ||
| Q1 24 | $2.6B | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $-6.0M |
| Free Cash FlowOCF − Capex | $30.1M | — |
| FCF MarginFCF / Revenue | 116.2% | — |
| Capex IntensityCapex / Revenue | 6.7% | — |
| Cash ConversionOCF / Net Profit | 4.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | $-6.0M | ||
| Q3 25 | $7.3M | $1.5M | ||
| Q2 25 | $6.4M | $-3.7M | ||
| Q1 25 | $9.3M | $-4.3M | ||
| Q4 24 | $30.4M | $-1.5M | ||
| Q3 24 | $9.6M | $-2.2M | ||
| Q2 24 | $7.7M | $-8.4M | ||
| Q1 24 | $5.1M | $39.0M |
| Q4 25 | $30.1M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $5.6M | — | ||
| Q1 25 | $9.1M | — | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $3.9M | — |
| Q4 25 | 116.2% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 121.1% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 31.2% | — | ||
| Q1 24 | 16.1% | — |
| Q4 25 | 6.7% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 4.7% | — |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
